Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A novel multi-epitope vaccine for SARS-CoV-2, targeting T cell epitopes, demonstrated immunogenicity in mice. This next-generation COVID-19 vaccine candidate shows promise for future human development.
Area Of Science
- Immunology
- Vaccinology
- Infectious Diseases
Background
- The COVID-19 pandemic, caused by SARS-CoV-2, has led to a global health crisis with millions of cases and deaths.
- Vaccination is a critical strategy for controlling the pandemic and preventing severe outcomes.
- There is a need for advanced vaccine platforms, such as multi-epitope vaccines, to enhance immune responses against SARS-CoV-2.
Purpose Of The Study
- To design and develop a next-generation multi-epitope vaccine for SARS-CoV-2 utilizing T cell epitopes.
- To assess the immunogenicity and immune response profile of the developed vaccine prototype in a preclinical mouse model.
Main Methods
- Immunoinformatic approaches were employed to select SARS-CoV-2 T cell epitopes with high MHC binding affinity.
- A multi-epitope vaccine prototype was synthesized, incorporating eleven selected peptide binders from SARS-CoV-2 proteins (E, M, S, N).
- Immunogenicity was evaluated in humanized-ACE2 transgenic mice using in vitro, in vivo, and ex vivo immunoassays, including lymphocyte profiling and cytokine analysis (IL-4, IFN-γ).
Main Results
- Eleven SARS-CoV-2 peptide epitopes were synthesized and formulated into a multi-epitope vaccine prototype.
- Vaccination in mice induced significant T cell responses, characterized by the production of IL-4 and IFN-γ.
- The vaccine remodeled lymphocyte profiles and elicited a weak humoral response.
Conclusions
- The developed multi-epitope vaccine prototype is immunogenic in a preclinical mouse model.
- This study provides a foundation for the construction of a potentially effective human vaccine against SARS-CoV-2.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Overview
The ability of a single antibody to recognize multiple structurally similar epitopes is an important immune defense strategy that enables the host to efficiently defend against many potentially threatening pathogens. However, cross-reactivity also elicits allergy symptoms against related allergens. It is increasingly important to understand the principles of cross-reactivity, as antibodies are actively being developed as therapeutic modalities for diverse diseases, including cancer.
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...